Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04650581 |
|---|---|
| Brief Title: | Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor (FINER) |
| First Submitted : | November 24, 2020 |
| First Submitted that Met QC Criteria : | December 1, 2020 |
| First Posted : | December 2, 2020 |
| Last Update Submitted that Met QC Criteria : | May 8, 2024 |
| Last Update Posted : | May 9, 2024 |